← Back to Search

Recovery Enhancement Program for Living Organ Donors

N/A
Waitlist Available
Led By Guiliano Testa, MD
Research Sponsored by Baylor Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages ≥ 18 years
Approved for evaluation to be a living liver or kidney donor
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from post-transplant discharge to 1 year follow-up
Awards & highlights

Study Summary

This trial will test if using certain resources before a transplant can help the patient recover better and faster after the transplant.

Who is the study for?
This trial is for adults over 18 who are approved to be evaluated as living liver or kidney donors. They must be cleared by a doctor to exercise, willing to follow the study's rules including an exercise plan and visits, and not have any health issues that prevent walking alone. Pregnant or breastfeeding individuals cannot participate.Check my eligibility
What is being tested?
The study is testing a Recovery Enhancement Program designed specifically for living organ donors. It aims to see if using pre-transplant resources helps achieve better and quicker recovery after donating an organ.See study design
What are the potential side effects?
Since this program involves an exercise regimen tailored for potential living donors, side effects might include typical risks associated with physical activity such as muscle soreness or strain but will vary based on individual health status.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am approved to be a living liver or kidney donor.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from post-transplant discharge to 1 year follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and from post-transplant discharge to 1 year follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Duration in ICU
Duration to return of daily activities
Incidence of Post-operative hospital re-admissions
+3 more

Trial Design

3Treatment groups
Active Control
Group I: Living Liver donorActive Control1 Intervention
Recovery enhancement program: At least 6 weeks of physical and relaxation skills training pre-transplant. Taking nutritional drink for 5 days before and after the surgery. Opioid sparing pain management.
Group II: Living Kidney donor (Control)Active Control1 Intervention
Subjects maintain the same lifestyle without practicing physical training, relaxation skills or nutritional drink before and after the surgery. To control post-op pain, subject will use medication per standard of care, including PCA pump.
Group III: Living Kidney donorActive Control1 Intervention
Recovery Enhancement Program At least 4 weeks of physical and relaxation skills training pre-transplant. Taking nutritional drink for 5 days before and after the surgery. Opioid sparing pain management.

Find a Location

Who is running the clinical trial?

Baylor Research InstituteLead Sponsor
200 Previous Clinical Trials
203,361 Total Patients Enrolled
Guiliano Testa, MDPrincipal InvestigatorSimmons Transplant Institute, Baylor University Medical Center

Media Library

Living Liver donor Clinical Trial Eligibility Overview. Trial Name: NCT03865264 — N/A
Living Liver and Kidney Donation Research Study Groups: Living Liver donor, Living Kidney donor (Control), Living Kidney donor
Living Liver and Kidney Donation Clinical Trial 2023: Living Liver donor Highlights & Side Effects. Trial Name: NCT03865264 — N/A
Living Liver donor 2023 Treatment Timeline for Medical Study. Trial Name: NCT03865264 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment presently open for this trial?

"According to clinicaltrials.gov, the study is not accepting any new candidates at present. This medical trial was made available on April 20th 2017 and last updated July 19th 2022; however, there are other active trials that require volunteers."

Answered by AI
~5 spots leftby Dec 2024